Home Page Hot Legal Issues Beyaz
Beyaz Birth Control
The US Food and Drug Administration (FDA) has issued a warning that women using birth control similar to Beyaz birth control could be at increased risk of drospirenone side effects. According to the FDA and researchers, drugs such as Beyaz birth control, which contain drospirenone are associated with an increased risk of blood clots. The FDA is now investigating potential Beyaz side effects and other drospirenone reactions. Although lawsuits have been filed against other birth control makers, so far no Beyaz lawsuits have been filed.
En Español [BEYAZ]
On September 26, 2011, the FDA issued a warning that the use of birth control medications that contain drospirenone could potentially be linked to an increased risk of blood clots. The announcement came after the FDA completed a review of two studies from 2011 that evaluated the risk of blood clots in women who use medications that contain drospirenone. Furthermore, the FDA has funded a study that evaluates the risk of blood clots in women who use hormonal birth control products. Preliminary results of that study suggest that women who take a birth control pill containing drospirenone has approximately 1.5 times the risk of blood clots of women who use other hormonal contraceptives.
Beyaz Side Effects
On May 31, 2011, the FDA issued an alert that the agency was assessing information about the risks associated with the use of drospirenone in birth control pills. According to the announcement, drospirenone is a type of female hormone called progestin.
"All birth control pills pose a risk of blood clots," the FDA announcement stated. "Several epidemiological studies have reported that the risk of blood clots for women who use birth control pills containing drospirenone is higher than that for women who use birth control pills containing the progestin levonorgestrel. Other studies have not reported an increase in risk."
On December 8, 2011, an FDA advisory panel ruled that birth control drugs containing drosperinone should include a warning about the risk of blood clots. The panel voted 21 to 5 that current warnings concerning the risk of blood clots were not strong enough and recommended that the FDA should strengthen those warnings. The panel voted 15 to 11 to keep drospirenone birth control medications on the market.
Blood clots can be serious, especially if they form in a deep vein (a condition called deep vein thrombosis, or DVT). If blood clots break loose from the vein and move to the lung, they can cause a pulmonary embolism, which can be fatal. According to the FDA, two recently published studies found an increased risk for blood clots in women taking drospirenone-containing pills compared with women taking levonorgestrel-containing pills.
A study published in the British Medical Journal (04/21/11) found that women who are currently using contraceptives that contain drospirenone had approximately three times the risk of developing a non-fatal idiopathic venous thromboembolism as women who used contraceptives that contain levonorgestrel.
Beyaz Blood Clots
"This study adds to the emerging evidence that use of the oral contraceptive containing drospirenone is associated with a higher risk of venous thromboemolism than are preparations containing levonorgestrel," researchers wrote. "Perhaps now is the time for a systematic review on this topic." They went on to note that there is no clear evidence that drospirenone pills have greater benefits than contraceptives that contain levonorgestrel, making drospirenone a less than ideal first line contraceptive.
Meanwhile, a second study also published in the British Medical Journal (04/21/11) found that woman who used birth control that contained drospirenone had approximately double the risk of non-fatal venous thromboembolism as women who used a birth control that contained levonorgestrel.
According to the website, Beyaz is a birth control pill that also provides a daily dose of folate, which is a B vitamin. Beyaz is approved to prevent pregnancy, provide daily folate supplementation and treat premenstrual dysphoric disorder. Beyaz is manufactured by Bayer HealthCare Pharmaceuticals.
Beyaz Legal HelpIf you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on Sep-16-14
BEYAZ LEGAL ARTICLES AND INTERVIEWS
Beyaz and Yasmin/Yaz: All in the Family
Washington, DC: Various pundits are left to wonder why the plethora of Beyaz side effects have led to little if any legal activity with regard to Beyaz side effects. Is it because Beyaz is so dramatically similar in chemical formulation to Yasmin and Yaz? The aforementioned chemical cousins of Beyaz are manufactured by Bayer HealthCare Pharmaceuticals (Bayer). All three are based on the synthetic hormone drospirenone, as well as estrogen. But there are thousands of lawsuits individually for Yasmin and Yaz, and some drospirenone lawsuits appear to now include Beyaz birth control as an automatic addendum [READ MORE]
Lawsuits Overlapping on Beyaz and Other Birth Control
Chicago, IL: Some medications are so different that despite treating similar conditions they have nothing in common. Other medications are so similar they get lumped into the same lawsuits. Such a situation has occurred with Beyaz side effects and other birth control side effects lawsuits. Beyaz, Yasmin and Yaz are so similar in composition and reported side effects, that some lawsuits combine two or three of them into one claim [READ MORE]
Bayer Still Quiet on Resolving Lawsuits Over Beyaz Side Effects
Washington, DC: With all the hype surrounding alleged side effects associated with Yasmin and Yaz, it remains odd that concern for Beyaz side effects on the part of the manufacturer appears to have fallen through the cracks. This is equally curious given the close association of the formulation upon which Beyaz is based, to Yaz [READ MORE]
MORE BEYAZ LEGAL NEWS
YOUR BEYAZ STORIES
Publish your Beyaz experience here for our readers to learn from.
READ MORE [ Drugs/Medical Settlements and Legal News ]